The global prevalence of Chlamydia pneumoniae, Helicobacter pylori, Cytomegalovirus and Herpes simplex virus in patients with coronary artery disease: A systematic review and meta-analysis

Abstract

Background and aimCoronary Artery Disease (CAD) is one of the most important causes of death worldwide. The aim of this study was to determine the prevalence of C. pneumoniae, H. pylori, Cytomegalovirus (CMV) and Herpes simplex virus (HSV) in CAD patients based on published serological and molecular studies. MethodsA systematic literature search was conducted in Medline (via PubMed), Embase, Scopus and Web of Science databases (1996–2019). Both molecular and serological studies were analyzed using STATA software (Version 14). Results145 studies were included for final analysis. We gathered and investigated the prevalence of C. pneumoniae (25.1% [95% confidence interval (CI) 21.5–28.8%]), H. pylori (12.8% [(95% CI) 4.0–22.0%]), CMV (64.4% [(95% CI) 57.7–73.0%]) and HSV (31.8% [(95% CI) 21.5–42.2%]) in CAD patients from the analysis of molecular studies. Additionally, in serological studies, the prevalence of mentioned pathogens were 72.7% [(95% CI) 67.8–77.6%], 63.3% [(95% CI) 60.0–66.5%], 62.2% [(95% CI) 58.0–66.3%] and 34.3% [(95% CI) 23.6–45.1%] respectively. ConclusionInterestingly, there was only a significant increase in the prevalence of C. pneumoniae and H. pylori in serological studies compared to the reported data from molecular studies, while the prevalence of CMV and HSV were the same in both types of studies.